These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15662615)

  • 1. von Willebrand disease and women's health.
    Lee CA; Abdul-Kadir R
    Semin Hematol; 2005 Jan; 42(1):42-8. PubMed ID: 15662615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand disease.
    James AH
    Obstet Gynecol Surv; 2006 Feb; 61(2):136-45. PubMed ID: 16433937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women and von Willebrand disease.
    Lee CA
    Haemophilia; 1999 May; 5 Suppl 2():38-45. PubMed ID: 23401898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.
    Reynen E; James P
    Semin Thromb Hemost; 2016 Oct; 42(7):717-723. PubMed ID: 27648611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of von Willebrand's disease in women - some answers, more questions.
    Kouides PA
    Haemophilia; 2006 Jul; 12 Suppl 3():143-51. PubMed ID: 16684010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than menorrhagia: a review of the obstetric and gynaecological manifestations of von Willebrand disease.
    James AH
    Thromb Res; 2007; 120 Suppl 1():S17-20. PubMed ID: 17482662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women and inherited bleeding disorders: menstrual issues.
    Lee CA
    Semin Hematol; 1999 Jul; 36(3 Suppl 4):21-7. PubMed ID: 10513768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor for menorrhagia: a survey and literature review.
    Ragni MV; Machin N; Malec LM; James AH; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brambilla DJ
    Haemophilia; 2016 May; 22(3):397-402. PubMed ID: 26843404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
    Ragni MV; Rothenberger SD; Feldman R; Nance D; Leavitt AD; Malec L; Kulkarni R; Sidonio R; Kraut E; Lasky J; Pruthi R; Angelini D; Philipp C; Hwang N; Wheeler AP; Seaman C; Machin N; Xavier F; Meyer M; Bellissimo D; Humphreys G; Smith KJ; Merricks EP; Nichols TC; Ivanco D; Vehec D; Koerbel G; Althouse AD
    Lancet Haematol; 2023 Aug; 10(8):e612-e623. PubMed ID: 37385272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of the Von Willebrand disease PREVENT trial.
    Ragni MV; Machin N; James AH; Seaman CD; Malec LM; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brooks MM
    Thromb Res; 2017 Aug; 156():8-13. PubMed ID: 28577390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Foster PA
    Thromb Haemost; 1995 Aug; 74(2):784-90. PubMed ID: 8585022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.
    Ragni MV; Jankowitz RC; Jaworski K; Merricks EP; Kloos MT; Nichols TC
    Thromb Haemost; 2011 Oct; 106(4):641-5. PubMed ID: 21833452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature.
    Brignardello-Petersen R; El Alayli A; Husainat N; Kalot MA; Shahid S; Aljabirii Y; Britt A; Alturkmani H; El-Khechen H; Motaghi S; Roller J; Abdul-Kadir R; Couper S; Kouides P; Lavin M; Ozelo MC; Weyand A; James PD; Connell NT; Flood VH; Mustafa RA
    Blood Adv; 2022 Jan; 6(1):228-237. PubMed ID: 34673921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Woman and von Willebrand disease].
    Hurskainen R; Halmesmäki E; Rasi V; Mäkipernaa A
    Duodecim; 2003; 119(1):33-40; quiz 40, 78. PubMed ID: 12607470
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
    James AH; Kouides PA; Abdul-Kadir R; Edlund M; Federici AB; Halimeh S; Kamphuisen PW; Konkle BA; Martínez-Perez O; McLintock C; Peyvandi F; Winikoff R
    Am J Obstet Gynecol; 2009 Jul; 201(1):12.e1-8. PubMed ID: 19481722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.